East Asia

East Asia spans countries including China, Japan, South Korea, and Taiwan. This archive gathers reported milestones from the region — covering public health, environmental efforts, technology, and social progress. Each entry highlights specific, verifiable developments worth knowing about.

Injecting vaccine, for article on India HPV vaccine

Indian company develops country’s first HPV vaccine

By / / Good News For Humankind

CERVAVAC, India’s first homegrown cervical cancer vaccine, is priced at just $2.50 to $5.00 per dose — a fraction of what HPV vaccines have cost in wealthy countries for nearly two decades. Developed by the Serum Institute of India, it protects against the HPV strains responsible for the majority of cervical cancers worldwide, and the company aims to produce around 200 million doses in its first two years. Cervical cancer is almost entirely preventable, yet it still kills hundreds of thousands of women each year, mostly in lower-income countries where vaccines have been priced out of reach. An affordable, locally made option doesn’t just change the math for India — it points toward a future where health tools belong to the people who need them most.

Space solar transmission project, for article on space solar power

China builds world-first full-function space solar verification tower

By / / Good News For Humankind

Space solar power just cleared a milestone that researchers once thought was still years away. China’s test tower at Xidian University is the first facility anywhere to run the complete chain — concentrating sunlight, converting it to electricity, and beaming that power wirelessly to a ground receiver — all in one integrated system, completed roughly three years ahead of schedule. It’s a research milestone, not a power plant, but proving the full system works in one place gives scientists a permanent platform to push the technology forward.

Vials of blood, for article on cancer diagnostics Africa, for article on Parkinson's blood test

First-of-a-kind blood test paves way for early Parkinson’s diagnosis

By / / Good News For Humankind

A simple blood test that could catch Parkinson’s disease before symptoms take hold is now closer to reality. Researchers at Kobe University developed an assay that reads changes in enzyme activity in a blood sample, achieving 85 to 88 percent accuracy in both human and rat models. Because treatments like levodopa and exercise work better early in the disease’s progression, earlier detection could meaningfully change what’s possible for patients. With Parkinson’s cases more than doubling globally over the past 25 years, affordable, scalable screening tools like this one could reshape how the world responds to the fastest-growing neurological disorder.